Mint Venture Partners
VC Fund
Seoul, South Korea
Mint Venture Partners is a global company builder creating startups and venture companies in the biotechnology and healthcare area. Its create values through commercialization, incubation & acceleration of innovative technologies as well as investment in early-phase startups around the world. Mint Venture envision to innovate the futurehealth as a global hub of biotech & healthcare industry.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Mint Venture Partners invests in
Stages Mint Venture Partners invests in
Countries Mint Venture Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Investment Focus
Industry
- Health Care 13 (65%)
- Medical Device 7 (35%)
- Biotechnology 6 (30%)
- Medical 5 (25%)
- Health Diagnostics 3 (15%)
Stage
- Series A 5 (25%)
- Series B 4 (20%)
- Seed 3 (15%)
- Series C 3 (15%)
- Pre-Seed 2 (10%)
Country
- South Korea 10 (50%)
- United States 6 (30%)
- Canada 1 (5%)
- United Kingdom 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dr. Jae-Hoon Song
Founder & Chairman
|
Founder & Chairman | Total investments: 0 | Find email | |
Alex Burke
Associate
|
Associate | Total investments: 0 | Find email | |
Brandon Song
Manager
|
Manager | Total investments: 0 | Find email | |
Dr. Hyunjin Ryu
Director of Business Development
|
Director of Business Development | Total investments: 0 | Find email | |
Kay M. Kim
Chief IP Officer
|
Chief IP Officer | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Beamworks is a research-centered company in medical imaging and conversational AI, that enables expert-level cancer diagnosis anywhere in the world and providing reliable medical consultations at any time. The company's platform utilizes an on-device AI system that processes ultrasound data in real-time without the need for serverconnectivity, achieving detection sensitivity and differential diagnosis performance, enabling healthcare providers to offer precise and timely diagnostics and improve patient outcomes, and reduce unnecessary procedures. | $10.9M / Venture - Series Unknown / Jun 02, 2025 | ||
| Ubix Therapeutics is a research and development company that develops anti-cancer drugs. | $17.7M / Series C / Dec 23, 2024 | ||
| The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective of developing therapeutic and diagnostic agents for neurological diseases, particularly Alzheimer's disease.In 2016, the company took significant steps toward formalizing its presence in the market by completing its incorporation andbusiness registration processes.The year 2017 proved to be a milestone for the company as it obtained certification as a corporate-affiliated research institute, solidifying its position as a reputable research-driven organization. Additionally, it garnered recognition as a leading university start-up by the Ministry of SMEs and Startups, further boosting its credibility and potential for growth.The company has collaborated with Oscotech Co., Ltd. and partnered with various investors, including Kite Entrepreneurship Foundation, Stone Bridge Ventures Co., Ltd., Korea Development Bank, and Stick Ventures Co., Ltd., to jointly develop their projects. | $12.4M / Series B / Jul 31, 2024 | ||
| Medinno develops cell therapeutics for brain diseases. The company's therapy uses technology to treat a wide range of diseases, including hypoxic-ischemic encephalopathy, neonatal refractory brain diseases, and severe intraventricular hemorrhages.. | $8.2M / Series C / Oct 16, 2023 | ||
| AIMEDBIO provides therapeutic solutions to patients with serious brain diseases. | Series A / Sep 12, 2023 | ||
| Humanscape is a rare disease health-tech company working to bring better chances of cure for patients. By collecting comprehensive patient health data from genotype, clinical to phenotype data and systematically compiling it into a complete, ready-to-use data set, pharmaceuticals and researchers can significantly reduce both time and cost for newdrug development. | $14.9M / Series C / May 12, 2023 | ||
| SanaHeal provider of a bioadhesive tape designed to bind to tissues or organs | Seed / Apr 01, 2022 | ||
| Activ Surgical is a digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes, and accessibility. Its scalable and patent-protected surgical software platform technology is driven by computer vision, artificial intelligence, analytics, and machine learning to enhance a surgeon’s intra-operative decision making,and reduce unintended and preventable surgical complications.The company was founded in 2017 and is headquartered in Boston, Massachusetts. | $15M / Series B / Mar 22, 2022 | ||
| Alzheimer’s Disease is one of the most prevalent neurodegenerative diseases causing insufferable pain to patients and their families. There are over 55 million people worldwide living with dementia, and Alzheimer’s Disease is the most common form of dementia. Unfortunately, the aging population will only exacerbate the prevalence of the disease,yielding immense medical costs in addition to the already devastating social burden. At BeauBrain Healthcare, we are revolutionizing the current treatment paradigm from “post-diagnosis treatment” to “pre-emptive intervention.”Our solutions enable early identification of the disease through predictive analysis of disease-specific biomarkers (Amyloid Beta, Tau, Neurodegeneration), and a personalized cognitive training platform (DTx). Ultimately, our long-term vision is to realize precision medicine for Alzheimer’s disease through the biomarker data generated from our diverse solutions combined with a vast amount of genetic data. | Pre-Seed / Feb 17, 2022 | ||
| Seawith is a South Korean startup developing cell-cultured steak from seaweed. | $838.6K / Series A / Jan 20, 2022 | ||
| See all 20 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Mint Venture Partners invest in?
Mint Venture Partners invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Series A and Series B stage. Most of the 20 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mint Venture Partners?
Public channels for Mint Venture Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mint Venture Partners?
The team at Mint Venture Partners includes Dr. Jae-Hoon Song (Founder & Chairman), Alex Burke (Associate) and Brandon Song (Manager), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
